Royalty Pharma PLC RPRX

58.21 0.56 0.97% as of 25 Sep
Market cap
$34.4B
P/E
40.1×
Growth Flags show if company had growth for consecutive years

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17
Cash and Short Term Investments
637.50 987.23 495.31 1,736.47 2,188.92 2,061.94 340.65 — —
Receivables
29.32 26.96 22.41 36.60 68.31 39.17 38.77 — —
Other current assets
861.28 787.96 756.48 781.84 620.98 595.79 452.65 — —
Total current assets
1,528.09 1,802.14 1,274.19 2,554.91 2,878.21 2,696.90 832.07 — —
Property, Plant, Equpment (Net)
16,208.48 15,127.16 14,088.66 13,493.11 13,718.25 12,368.08 10,842.05 — —
Long-Term Investments
880.28 1,259.88 1,012.48 735.82 909.59 916.64 678.41 — —
Goodwill and Intangible Assets (Total)
924.63 — — — 5.67 28.67 51.72 0.00 —
Long-term assets (Other)
79.29 33.53 6.52 29.63 4.15 10.00 45.64 — —
Total non-current assets
18,092.69 16,420.58 15,107.66 14,258.56 14,637.65 13,323.39 11,617.82 — —
Total Assets
19,620.78 18,222.71 16,381.85 16,813.47 17,515.87 16,020.29 12,449.89 0.00 0.00
Accounts Payable
19.40 13.37 15.17 7.91 5.62 10.78 11.18 — —
Accrued Expenses
110.82 98.06 51.68 54.16 57.70 152.15 — — —
Current Part of Debt
380.00 997.77 — 997.51 — — 291.20 — —
Current Part of Capital Lease
— — — — — — — 0.00 —
Current Part of Taxes to Pay
— — — — — — — 0.00 —
Other current liabilities
53.16 68.60 11.38 12.40 — — — — —
Total current liabilities
636.21 1,253.62 161.38 1,166.78 171.25 307.89 333.42 — —
Long Term Debt (Total)
8,570.92 6,614.65 6,135.29 6,118.81 7,096.07 5,816.58 5,975.04 — —
Non-current Revenue (Deferred)
— — — — — — — 0.00 —
Minority Interests
— — — — — — — 0.00 —
Non-current Liabilities (Other)
698.71 12.08 0.90 2.50 — — — — —
Total non-current liabilities
9,269.63 6,626.73 6,136.19 6,121.31 7,096.07 5,816.58 5,975.04 — —
Total liabilities
9,905.84 7,880.35 6,297.56 7,288.09 7,267.32 6,124.47 6,308.46 0.00 —
Additional Paid In Capital
4,123.09 4,103.48 4,011.44 3,666.16 3,507.53 2,865.96 — 0.00 —
Preferred Stock (Total)
— — — — — — — 0.00 —
Common Stock (Net)
0.11 0.11 0.11 0.11 0.11 0.10 — 0.00 —
Retained Earnings
2,356.32 2,845.65 2,517.58 1,964.69 2,255.18 1,920.64 2,825.21 — —
Equity Equivalent
— — — — — — 3,282.52 — —
Treasury Stock
2.61 2.66 2.63 2.81 2.72 2.32 4.27 0.00 —
Shareholders Equity (Other)
— — — — — — — 0.00 —
Common Equity (Total)
9,714.94 10,342.37 10,084.29 9,525.37 10,248.54 9,895.82 6,141.44 — —
Shareholders Equity (Total)
9,714.94 10,342.37 10,084.29 9,525.37 10,248.54 9,895.82 6,141.44 0.00 —
Shareholders Equity and Liabilities (Total)
19,620.78 18,222.71 16,381.85 16,813.47 17,515.87 16,020.29 12,449.89 0.00 —
Shares (Common)
988.63 981.42 982.13 978.60 968.05 923.05 — — —
Shareholders Equity (Tangible)
8,790.31 10,342.37 10,084.29 9,525.37 10,242.88 9,867.15 6,089.71 — —
Net Debt
8,313.42 6,625.20 5,639.98 5,379.85 4,907.15 3,754.64 5,925.59 — —
Total Debt
8,950.92 7,612.43 6,135.29 7,116.32 7,096.07 5,816.58 6,266.24 — —

Fold the line items

In millions of $ except per-share values · columns are period end dates